MedTrace Logo

Biomarker Study for Alzheimer's Disease

NCT02472899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2021-01-27

No results posted yet for this study

Summary

The study aims to identify immune biomarkers in peripheral blood for identifying Alzheimer's disease (AD). Blood samples from subjects with AD will be compared to age-matched controls without cognitive symptoms, as well as healthy younger subjects.

Conditions

Interventions

OTHER

Blood sample

Non-interventional study based on blood samples taken at a single study visit

Sponsors & Collaborators

  • Beersheva Mental Health Center

    lead OTHER_GOV

Principal Investigators

  • Tzvi Dwolatzky, MD · Beersheva Mental Health Center

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Israel

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02472899 on ClinicalTrials.gov